Please Wait
Applying Filters...
Menu
Xls

Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2026/01/09/3216206/0/en/SEED-Therapeutics-Doses-First-Patient-in-Phase-1-Trial-of-ST-01156-a-Molecular-Glue-Degrader-Targeting-RBM39.html

GLOBENEWSWIRE
09 Jan 2026

https://www.globenewswire.com/news-release/2025/08/11/3130780/0/en/FDA-Clears-IND-for-SEED-Therapeutics-RBM39-Degrader-ST-01156.html

GLOBENEWSWIRE
11 Aug 2025